Toroso Investments »

Enliven Therapeutics shares owned by Toroso Investments

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Toroso Investments from 13F filings

Historical chart of Toroso Investments investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Toroso Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Toroso Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 48k 39.20
2024-06-30 $411k 18k 23.37

More positions owned by Toroso Investments

NVIDIA Corporation (NVDA)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Coinbase Global Com Cl A (COIN)
Amazon (AMZN)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
First Majestic Silver Corp Call Option (AG)
Broadcom (AVGO)
Robinhood Mkts Com Cl A (HOOD)

View all positions for Toroso Investments

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics